治疗创新:以天然和合成化合物为目标,针对AML中的ROS生产
Mohammed Hashim Mohammed1, Raed Fanoukh Aboqader Al-Aouadi2, Subasini Uthirapathy3
1Medical Laboratory Techniques Department, College of Health and Medical Technology, Al-Maarif University, Anbar, Iraq. Muhammad.hashem@uoa.edu.iq.
活性氧物种 (ROS) 通过影响细胞通路影响急性髓性白血病 (AML). 针对ROS提供治疗潜力,但在AML治疗的临床应用方面面临挑战.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 细胞生物学 细胞生物学
背景情况:
- 反应性氧物种 (ROS) 在急性髓性白血病 (AML) 病理生理学中起着复杂的作用.
- 在AML中,ROS充当信号分子和细胞损伤的调解者.
研究的目的:
- 为提供AML中ROS产生的深入分析.
- 探索ROS对控制生存,增殖和亡的细胞通路的影响.
- 评估针对ROS的药理学药剂,并确定与ROS相关的预后生物标志物.
主要方法:
- 关于AML中的ROS产生和功能的文献综述.
- 对调节ROS的自然和合成剂的分析.
- 鉴定与ROS相关的预后生物标志物.
主要成果:
- 在AML中,ROS显著影响关键细胞通路.
- 针对ROS的药理学药剂显示出治疗前景,但存在临床挑战.
- 与ROS相关的生物标志物可以帮助AML患者分层.
结论:
- 在AML中准ROS通路具有治疗潜力.
- 需要进一步的研究来克服ROS动态和阻力机制等挑战.
- 完善针对ROS的策略对于改善AML治疗结果至关重要.
更多相关视频
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
10:05Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
Published on: May 8, 2020
相关概念视频
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Differentiation of Common Myeloid Progenitor Cells
